相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
Janis V. de la Iglesia et al.
CLINICAL CANCER RESEARCH (2020)
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open -label phase III study
R. L. Ferris et al.
ANNALS OF ONCOLOGY (2020)
Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).
Robert L. Ferris et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Correlation of tumor mutational burden (TMB) with CDKN2A and TP53 mutation in HPV-negative head and neck squamous cell carcinoma (HNSCC).
Barbara Burtness et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck (JCOG1008).
Naomi Kiyota et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Plasma-based tumor mutational burden (bTMB) as predictor for survival in phase III EAGLE study: Durvalumab (D) ± tremelimumab (T) versus chemotherapy (CT) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum failure.
Weimin Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Trends in Incidence of Cancers of the Oral Cavity and Pharynx - United States 2007-2016
Taylor D. Ellington et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
Apostolos Klinakis et al.
EBIOMEDICINE (2020)
De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies
Hisham Mehanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study
H. Mehanna et al.
ANNALS OF ONCOLOGY (2020)
Role of gene signatures combined with pathology in classification of oropharynx head and neck cancer
Andrew Dhawan et al.
SCIENTIFIC REPORTS (2020)
Survival Outcomes in Human Papillomavirus-Associated Nonoropharyngeal Squamous Cell Carcinomas A Systematic Review and Meta-analysis
Axel Sahovaler et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)
Head and neck squamous cell carcinoma
Daniel E. Johnson et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Efficacy of first-line (1L) pembrolizumab by PD-L1 combined positive score <1, 1-19, and ≥20 in recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): KEYNOTE-048 subgroup analysis
Barbara Burtness et al.
CANCER RESEARCH (2020)
Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
Sun Min Lim et al.
CANCER RESEARCH AND TREATMENT (2019)
HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck
Vanessa B. Wookey et al.
ANTICANCER RESEARCH (2019)
Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base
Sibo Tian et al.
CANCER (2019)
Analysis of early mortality in randomized clinical trials evaluating anti-PD-1/PD-L1 antibodies: A systematic analysis by the United States Food and Drug Administration (FDA).
Flora Mulkey et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review
Barbora Peltanova et al.
MOLECULAR CANCER (2019)
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group
T. Eder et al.
EUROPEAN JOURNAL OF CANCER (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
1114PDHigh immunoscore is associated with good response to neo-adjuvant chemotherapy and prolonged survival in advanced head and neck cancer patients
H Mirghani et al.
ANNALS OF ONCOLOGY (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
Robert Motzer et al.
LANCET ONCOLOGY (2019)
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
Dan P. Zandberg et al.
EUROPEAN JOURNAL OF CANCER (2019)
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Ezra E. W. Cohen et al.
LANCET (2019)
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna et al.
LANCET (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Characteristics and impact of programmed death-ligand 1 expression, CD8+tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma
Nuttapong Ngamphaiboon et al.
MEDICAL ONCOLOGY (2019)
Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma
Axel Lechner et al.
ONCOIMMUNOLOGY (2019)
Association Between Head and Neck Squamous Cell Carcinoma Survival, Smoking at Diagnosis, and Marital Status
Nosayaba Osazuwa-Peters et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)
Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing
I. H. Nauta et al.
ANNALS OF ONCOLOGY (2018)
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Ranee Mehra et al.
BRITISH JOURNAL OF CANCER (2018)
The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients
Minglei Zhuo et al.
CANCER BIOMARKERS (2018)
Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group
Thomas Melchardt et al.
EUROPEAN JOURNAL OF CANCER (2018)
Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma
Xue-Mei Zhang et al.
HUMAN PATHOLOGY (2018)
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Vanita Noronha et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas
Alexis Desrichard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Robert L. Ferris et al.
ORAL ONCOLOGY (2018)
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas
Alexis Desrichard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal squamous cell carcinoma
H. P. Sathasivam et al.
ANNALS OF ONCOLOGY (2018)
Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial
A. D. Colevas et al.
ANNALS OF ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Biomarkers predictive of response to pembrolizumab in head and neck cancer (HNSCC)
Tanguy Y. Seiwert et al.
CANCER RESEARCH (2018)
PD-L1 expression in patients screened for phase 2 head and neck squamous cell carcinoma clinical studies (HAWK and CONDOR)
Sophie Wildsmith et al.
CANCER RESEARCH (2018)
Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy in Lung Cancer
Manuel D. Gil-Sierra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis
Wei-fa Yang et al.
ORAL ONCOLOGY (2018)
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
Nataly Manjarrez-Orduno et al.
FRONTIERS IN IMMUNOLOGY (2018)
Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015
Elizabeth A. Van Dyne et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
LBA8_PRKEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)
B Burtness et al.
ANNALS OF ONCOLOGY (2018)
Frameshift events predict anti-PD-1/L1 response in head and neck cancer
Glenn J. Hanna et al.
JCI INSIGHT (2018)
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy
Erin Larkins et al.
ONCOLOGIST (2017)
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
Tim Mueller et al.
ONCOTARGET (2017)
The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
Emma J. de Ruiter et al.
ONCOIMMUNOLOGY (2017)
Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype
Andreas E. Albers et al.
SCIENTIFIC REPORTS (2017)
Genomic determinants of response to pembrolizumab in head and neck squamous cell carcinoma (HNSCC).
Robert I. Haddad et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
E. E. W. Cohen et al.
ANNALS OF ONCOLOGY (2017)
Tumor evolution: Linear, branching, neutral or punctuated?
Alexander Davis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
The promise of immunotherapy in head and neck squamous cell carcinoma
P. Economopoulou et al.
ANNALS OF ONCOLOGY (2016)
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma
Adil I. Daud et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab
David I. Rosenthal et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study
Brian O'Sullivan et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Stromal CD8+ T-cell Density-A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer
Tom Donnem et al.
CLINICAL CANCER RESEARCH (2015)
Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials
Aarti Bhatia et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome
Yi Huang et al.
ONCOTARGET (2015)
Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
Simona Partlova et al.
ONCOIMMUNOLOGY (2015)
Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas
Tanguy Y. Seiwert et al.
CLINICAL CANCER RESEARCH (2015)
Human papillomavirus and cancerous diseases of the head and neck: a systematic review and meta-analysis
R. Saulle et al.
ORAL DISEASES (2015)
Different Levels in Alcohol and Tobacco Consumption in Head and Neck Cancer Patients from 1957 to 2013
Yu Zhang et al.
PLOS ONE (2015)
High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
Yueh-Min Lin et al.
PLOS ONE (2015)
Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials
A. Argiris et al.
ANNALS OF ONCOLOGY (2014)
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial
J. B. Vermorken et al.
ANNALS OF ONCOLOGY (2014)
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
M. J. Ward et al.
BRITISH JOURNAL OF CANCER (2014)
Smoking at Diagnosis Is an Independent Prognostic Factor for Cancer-Specific Survival in Head and Neck Cancer: Findings from a Large, Population-Based Study
Linda Sharp et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Betel quid chewing and the risk of oral and oropharyngeal cancers: A meta-analysis with implications for cancer control
Neela Guha et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
Phuc Felix Nguyen-Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
Cathy Ndiaye et al.
LANCET ONCOLOGY (2014)
Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Annah Wyss et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma
Cecilia Nordfors et al.
EUROPEAN JOURNAL OF CANCER (2013)
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancersystematic review and meta-analysis of trends by time and region
Hisham Mehanna et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway
Ashley Cimino-Mathews et al.
HUMAN PATHOLOGY (2013)
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Jan B. Vermorken et al.
LANCET ONCOLOGY (2013)
Trends over three decades of the risk of second primary cancer among patients with head and neck cancer
Jeremie Jegu et al.
ORAL ONCOLOGY (2013)
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study
R. Granata et al.
ANNALS OF ONCOLOGY (2012)
Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer
Maura L. Gillison et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
Kasper Toustrup et al.
CANCER RESEARCH (2011)
TOBACCO SMOKING DURING RADIATION THERAPY FOR HEAD-AND-NECK CANCER IS ASSOCIATED WITH UNFAVORABLE OUTCOME
Allen M. Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
Tobacco Use in Human Papillomavirus-Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence
Jessica H. Maxwell et al.
CLINICAL CANCER RESEARCH (2010)
Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
Danny Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A GENE EXPRESSION MODEL OF INTRINSIC TUMOR RADIOSENSITIVITY: PREDICTION OF RESPONSE AND PROGNOSIS AFTER CHEMORADIATION
Steven A. Eschrich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Pretreatment Health Behaviors Predict Survival Among Patients With Head and Neck Squamous Cell Carcinoma
Sonia A. Duffy et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells
Theodore Rampias et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas
Harriet C. Hafkamp et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Tailoring to RB: tumour suppressor status and therapeutic response
Erik S. Knudsen et al.
NATURE REVIEWS CANCER (2008)
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer:: Pooled analysis in the international head and neck cancer epidemiology consortium
Mia Hashibe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Human papillomavirus and head and neck cancer: a systematic review and meta-analysis
C. G. L. Hobbs et al.
CLINICAL OTOLARYNGOLOGY (2006)
分享论文
